Peer Reviewed Manuscripts

1. McCarthy Jr PL, Shaw JE, Remold HG.  The Role of Microtubules in the Response of the Macrophage to Migration Inhibitory Factor.  Cell Immunol 46:409-415, 1979.
2. Remold HG, Mednis AD, McCarthy Jr PL.  Studies of MIF and the Role of Macrophage Associated Esterases in the Response of the Macrophage to MIF.  Adv Exp Med Biol 114:465-468, 1979.
3. Remold HG, McCarthy Jr PL,  Mednis AD.  Purification of Guinea Pig pH 3 Migration Inhibitory Factor.  Proc Natl Acad Sci USA 78:4088-4091, 1981.
4. Fox H, McCarthy Jr PL, Andre-Schwartz J, Schoenfeld Y, Miller KB.  Gaucher's Disease and Chronic Lymphocytic Leukemia;  Possible Pathogenetic Link Between Gaucher's Disease and B-Cell Proliferations?  Cancer 54:312-314, 1984.
5. Szyf M, Tanigawa G, McCarthy Jr PL.  A DNA Signal from the Thy-1 Gene Defines de novo Methylation Patterns in Embryonic Stem Cells.  Mol Cell Biol 10:4396-4400, 1990.
6. McCarthy Jr PL, Ahhyankar S, Neben S, Newman G, Sieff C, Thompson RC, Burakoff SJ, Ferrara JLM.  The Inhibition of Interleukin-1 by an Interleukin-1 Receptor Antagonist Prevents Graft Versus Host Disease.  Blood 78:1915-1918, 1991.
7. Newman GW, Gan HX, McCarthy Jr PL, Remold HG.  Survival of Human Macrophages Infected with Mycobacterium avium intracellulare Correlates with Increased Production of Tumor Necrosis Factor-a and IL-6.  J Immunol 147:3942-3948, 1991.
8. Ballen KK, Donadio D, Bouloux C, McCarthy P, Weinstein H, Antin J.  Herpes Simplex Virus and Neutropenia Following Bone Marrow Transplantation.  Transplantation 54:553-555, 1992.
9. Gan H, Newman G, McCarthy PL, Remold HG.  TNF-a Response of Human Monocyte Derived Macrophages to Mycobacterium avium serovar 4 is of Brief Duration and Protein Kinase C Dependent.  J Immunol 150:2892-2900, 1993.
10. Wheeler C, Hunt M, Ayash L, Churchill WH, Bierer BE, Elias A, Gilliland DG, Antman K, Guinan EC, Eder JP, Weinstein H, Schwartz G, Ferrara J, Mazanet R, Rimm I, Tepler I, McCarthy PL, Mauch P, Ault K, Gaynes L, McCauley M, Schnipper LE, Antin J.  Prognostic Factors for Treatment Outcome in Autotransplantation of Intermediate and High Grade Non-Hodgkin's Lymphoma with Cyclophosphamide, Carmustine and Etoposide (CBV).  J Clin Oncology 11:1085-1091, 1993.
11. Antin JH, Weinstein HJ, Guinan EC, McCarthy P, Bierer B, Gilliland DG, Parsons S, Ballen K, Rimm I, Falarone G, Bloedow DC, Abate L, Lebsack M, Burakoff SJ, Ferrara JLM.  Recombinant Human Interleukin-1 Receptor Antagonist in the Treatment of Steroid-Resistant Graft-Versus-Host-Disease.  Blood 84:1342-1348, 1994.
12. van Besien KW, Khouri IF, Giralt SA, McCarthy P, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Bellare N, Nath R, Romaguera JE, McLauglin PW, Korbling M, Deisseroth AB, Cabanillas FF, Champlin RE.  Allogeneic Bone Marrow Transplantation for Refractory and Recurrent Low Grade Lymphoma:  The Case for Aggressive Management.  J Clin Oncol 13:1096-1102, 1995.
13. Peters WP, Fay JW, Holland HK, Ahmed T, Bolwell BJ, Wolf J, Damon L, Long G, Schwartzberg LS, Goldberg SL, Friedman DJ, Lynch JP, Weinberger BB, Taylor RF, Stadtmauer E, Rifkin RM, Broun ER, McCarthy PL, Zamkoff K, Petersen FB, Reed EC, Mills L, Schuster MW, Lazarus HW, Fruchtman SM, Hesdorffer CS, Douer D, Flomenberg J, Guarino MJ, Maziarz RT, Elfenbein GJ, LeMaistre CF, Kard L, Cirrincione C.  Autologous Bone Marrow Transplantation in Primary Breast Cancer: the American Experience.  Bone Marrow Transplant 15 (suppl 1):S254-259, 1995.
14. Weinberg AD, Kripalani S, McCarthy PL, Schull WJ.  Caring for Survivors of the Chernobyl Disaster: What the Clinician Should Know.  JAMA 274:408, 1995.
15. Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL, Pavlovsky S, Petersen FB, Rowlings PA, Russell JA, Silver SM, Vose JM, Wiernik PH, Bortin MM, Horowitz MM.  Bone Marrow Transplants from HLA-Identical Siblings in Advanced Hodgkin Disease.  J Clin Oncol 14:572-578, 1996.
16. van Besien KW, Mehra RC, Giralt SA, Kantarjian HM, Pugh WC, Khouri IF, Moon Y, Williams P, Andersson BS, Przepiorka D, McCarthy PL, Gajewski JL, Deisseroth AB, Cabanillas FF, Champlin R. Allogeneic Bone Marrow Transplantation for Poor-Prognosis Lymphoma - Response, Toxicity, and Survival Depend on Disease Histology.  Am J Med 100:299-307, 1996.
17. McCarthy Jr PL, Williams L, Harris-Bacile M, Przepiorka D, Ippoliti C, Champlin R, Blosch C, Jacobs C, Anasetti C.  A Clinical Phase I/II study of Recombinant Human Interleukin-1 Receptor (rhuIL-1R) in Steroid-Resistant Graft-Versus-Host Disease.  Transplantation 63:626-631, 1996.
18. Lonial S, Williams L, Carrum G, Ostrowski M, McCarthy Jr PL.  Neosartorya Fischeri: an Invasive Pathogen in an Allogeneic Bone Marrow Transplant Patient.  Bone Marrow Transplant 19:753-755, 1997.
19. Antman KH, Rowlings PA, Vaughn WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner B, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy Jr PL, Saez R, Spitzer GL, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM. High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Support for Breast Cancer in North America. J Clin Oncol 15:1870-1879, 1997.
20. Peterson LE, Dreyer ZE, Plon SE, Smith JL, Weinberg AD, McCarthy PL. Design and Analysis of Epidemiologic Studies of Excess Cancer Among Children Exposed to Chernobyl Radionuclides. Stem Cells 15 (suppl 2):211-230, 1997.
21. Yavorkovsky L, Carrum G, Bruce S, McCarthy Jr PL. Cutaneous Sarcoidosis in a Patient with Philadelphia-Positive Chronic Myelogenous Leukemia Treated with Interferon-Alpha.  Am J Hematol 58:80-18, 1998.
22. van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy Jr PL, Raemaekers JM, Reiffers J, Phillips GL, Schattenberg AV, Verdonck LF, Vose JM, Horowitz MM.  Allogeneic Bone Marrow Transplantation for Low Grade Lymphoma.  Blood 92:1832-1836, 1998.
23. Proulx GM, McCarthy P. Complications of Acute Leukemia. Case Two: Epidural Chloroma of the Lower Spinal Canal. J Clin Oncol 16:3201-3202, 1998.
24. McCarthy PL, Hurd D, Rowlings PA, Crump M, Gale R, Lazarus H, Vaughan W, Weinberger B, Wiemann M, Freytes C, Cirenza E, Antman KS.  Autotransplants in Men with Breast Cancer. Bone Marrow Transplant 24: 365-368, 1999.
25. Alidina A, Lawrence D, Ford LA, Baer MR, Bambach B, Bernstein S, Czuczman MS, Slack J, Spangenthal E, Wetzler M, Barcos MP, Proulx G, Anderson B, McCarthy Jr PL, Thiotepa-associated cardiomyopathy during blood or marrow transplantation association: association with female gender and cardiac risk factors. Biol Blood Marrow Transplantation, 5:322-327, 1999.
26. Rowlings, PA, Williams, SF, Antman, KH, Fields, KK, Fay, JW, Reed, E. Pelz, CJ, Klein, JP, Sobocinski, KA, Kennedy, J., Freytes, CO, McCarthy Jr PL, Herzig, RH, Stadtmauer, EA, Lazarus, HM, Pecora, AL,  Bitran, JD, Wolff, SN, Gale, RP,  Armitage, JO,  Vaughan, WP,  Spitzer, G., and Horowitz, M.  Factors correlated with progression-free survival after high-dose therapy and hematopoietic stem cell transplantation for metastatic breast cancer. JAMA, 14:1335-1343, 1999.
27. Ray, Jr CE, Shenoy SS, McCarthy Jr PL, Broderick KA, Kaufman JA.  Weekly prophylactic urokinase instillation in tunneled central venous access devices.  Vasc Interv Radiol, 10:1330-1334, 1999.
28. Proulx GM, El-Agamawi AY, Lee RJ, Orner JB, Czuczman M, McCarthy P, Bernstein Z, Bernstein S.  Primary non-Hodgkin’s lymphoma of bone:  treatment and outcome.  Radiol Oncol; 34(1): 27-33, 2000
29. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P.  Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis.  Bone Marrow Transplant, 25 (12): 1299-1301, 2000
30. Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM.  Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission.  Blood, 96 (4):  1254-1258, 2000.
31. Li LH, McCarthy P, Hui SW.  High-efficiency electrotransfection of human primary hematopoietic stem cells.  FASEB, 15, 1-4, 2001.
32. Simon M, Hahn T, Ford L, Anderson B, Swinnich D, Baer M, Bambach B, Bernstein S, Bernstein Z, Czuczman M, Slack J, Wetzler M, Herzig G, Schriber J, McCarthy PL. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood and marrow transplantation (BMT): possible beneficial use of low molecular weight heparin. Bone Marrow Transplant, 27, 627-633, 2001.
33. Khushalani NI, Bakri FG, Wentling D, Brown K, Mohr A, Anderson B, Keesler C, Ball D, Bernstein ZP, Bernstein SH, Czuczman MS, Segal BH, McCarthy Jr PL.  Respiratory syncytial virus infection in the late bone marrow transplant period:  Report of three cases and review.  Bone Marrow Transplant, 27, 1071-1073, 2001.
34. Hahn T, Wolff SN, Czuczman M, Fisher RI, Lazarus HM, Vose J, Warren L, Watt R, McCarthy Jr PL.  The Role of Cytotoxic Therapy With Hematopoietic Stem Cell Transplantation in the Therapy of Diffuse Large Cell B-Cell Non-Hodgkin’s Lymphoma: An Evidence-Based Review.  Biol Blood Marrow Transplantation 7:308-331, 2001
35. Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy Jr PL, Norton L, Parnes H, Pecora A, Perry MC, Rowlings P, Spitzer G, Horowitz MM.  High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the autologous blood and marrow transplant registry.  J Clin Oncol 20(3):743-750, 2002.
36. Czuczman MS, Fallon A, Mohr A, Stewart C, Bernstein ZP, McCarthy P, Skipper M, Brown K, Miller K, Wentling D, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez AJ, Bernstein SH.  Rituximab in combination with CHOP or Fludarabine in low-grade lymphoma.  Seminars in Oncology 29(1) (suppl 2): 36-40, 2002.
37. Ahmad I, Islam T, Chanan-Khan A, Hahn T, Wentling D, Becker JL, McCarthyJr  PL, Alam AR. Thalidomide as salvage therapy for VAD-refractory multiple myeloma patients prior to autologous PBSCT. Bone Marrow Transplant 29:577-80, 2002.
38. Weisdorf D, Bishop M, Dharan B, Bolwell B, Cahn JY, Caziro M, Giralt S, Klein J, Lazarus H, Litzow M, Marks D, McCarthy P, Miller C, Milone G, Russell J, Schultz KR, Sierra J, Wiernik P, Keating A, Loberiza F, Kollman C, Horowitz, M.  Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia:  comparative toxicity and outcomes.  Biology of Blood and Marrow Transplant 8:213-220, 2002.
39. Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM. Severity of chronic graft versus-host disease: association with treatment-related mortality and relapse. Blood. 2002 Jul 15;100(2):406-14
40. Hahn T, Cummings KM, Michalek AM, Lipman BJ, Segal BH, McCarthy, Jr PL.  Efficacy of high efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies.  Inf Control Hosp Epi 23:525-532, 2002.
41. Zamostian P, Moysich KB, Mahoney MC, McCarthy P, Bondar AY, Noschenko AG, Michalek AR.  Influence of various factors on individual radiation exposure from the Chernobyl disaster. Environmental Health:  A Global Access Science Source 1:4, 2002.  Available from:  http://www.ehjournal.net
42. Litzow MR, Perez WS, Klein JP, Bolwell BJ, Camitta B, Copelan EA, Gale RP, Giralt SA, Keating A, Lazarus HM, Marks DI, McCarthy PL, Miller CB, Milone G, Prentice HG, Russell JA, Schultz KR, Trigg ME, Weisdorf DJ, Horowitz MM.  Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. Br J Haematol. 119:1115-24, 2002.
43. Hahn T, Wingard J, Anderson K, Bensinger W, Berenson J, Brozeit G, Carver J, Kyle R, McCarthy, Jr PL.  The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma:  an evidence based review.  Biology of Blood and Marrow Transplant 9:4-37, 2003.
44. Benekli M, Hahn T, Shafi F, Qureshi A, Alam AR, Czuczman MS, Bernstein ZP, Chanan-Khan AA, Becker JL, McCarthy PL.  Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients.  Bone Marrow Transplant 32:139-43, 2003.
45. Hahn T, Bunworasate U, George MC, Bir AS, Chinratanalab W, Alam AR, Bambach B, Baer MR, Slack JL, Wetzler M, Becker J, McCarthy PL.  Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment.  Bone Marrow Transplant 32:145-50, 2003.
46. Gruber M, Kane K, Flack L, Abbotoy J, Recchio J, Williamson K, Horan K, McCarthy P.  A "perfect day" work redesign in a chemotherapy and infusion center. Oncol Nurs Forum. 30:567-8, 2003.
47. Hahn T, Rondeau C, Shaukat A, Jupudy V, Miller A, Alam AR, Baer MR, Bambach B, Bernstein Z, Chanan-Khan AA, Czuczman MS, Slack J, Wetzler M, Mookerjee BK, Silva J, McCarthy PL.  Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients.  Bone Marrow Transplant 32:405-410, 2003.
48. Reece DE, Bredeson C, Perez WS, Jagannath S, Zhang MJ, Ballen KK, Elfenbein GJ, Freytes CO, Gale RP, Gertz MA, Gibson J, Giralt SA, Keating A, Kyle RA, Maharaj D, Marcellus D, McCarthy PL, Milone GA, Nimer SD, Pavlovsky S, To LB, Weisdorf DJ, Wiernik PH, Wingard JR, Vesole DH.  Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age.  Bone Marrow Transplant 32:1135-1143, 2003.
49. Vose JM, Rizzo JD, Tao-Wu J, Armitage JO, Bashey A, Burns LJ, Christiansen NP, Freytes CO, Gale RP, Gibson J, Giralt SA, Herzig RH, Lemaistre CF, McCarthy, Jr PL, Nimer SD, Petersen FB, Schenkein DP, Wiernik PH, Wiley JM, Loberiza FR, Lazarus HM, vanBiesen K, Horowitz MM.  Autologous transplantation for diffuse aggressive non-Hodgkin’s lymphoma in first relapse or second remission.  Biol Blood Marrow Transplant 10:116-27, 2004.
50. Dibo I, Pillai SK, Moellering RC, Gold HS, Baer MR, Wetzler M, Slack J, Ball D, Hsiao CB, McCarthy, Jr PL, Segal BH. Linezolid-resistant Enterococcus Faecalis Isolated from a Hematopoietic Transplant Recipient. J of Clini Microbiol 42:1843-1845, 2004.
51. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Perez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low risk myelodysplasia is associated with improved outcome. Blood. Jul 15;104(2):579-85. Epub 2004 Mar 23, 2004.
52. Lee SJ, Zahrieh D, Agura E, MacMillan ML, Maziarz RT, McCarthy PL, Ho VT, Cutler C, Alyea EP, Antin JH, Soiffer RJ.  Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-vs.-host disease: results of a randomized trial. Blood. 2004 Sep 1;104(5):1559-64. Epub 2004 May 11.
53. Chanan-Khan A, Islam T, Alam A, Miller KC, Gibbs J, Barcos M, Czuczman MS, Paplham P, Hahn T, McCarthy P.  Long-term survival with allogeneic stem cell transplant following salvage therapy with anti-CD52 monoclonal antibody (Campath®) in a patient with α/β hepatosplenic T-cell non-Hodgkin’s lymphoma.  Leukemia & Lymphoma.  45:1673-1675, 2004.
54. Mahoney MC, Lawvere S, Falkner KL, Averkin YI, Ostapenko VA, Michalek AM Moysich KB, McCarthy PL. Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. Int Journal Epidemiology, 33, 1025-1033, 2004.
55. Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, Van Besien K. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who relapse after autologous stem cell transplantation for lymphoma: a report of the international bone marrow transplant registry. Blood. 2004 Jul 27 [Epub ahead of print] Blood. Dec 1;104(12):3797-803, 2004.
56. McCarthy Jr PL, Paltiel O, Maslova E, Kulikov S, Hahn T, Kopecky KJ, Drozdova V, Shmatina N, Tichonova L, Van Hoff J, Gavrilova I, Weinstein W,  Histopathologic Verification of Acute Leukemia (AL) in a Cohort of 463 Post-Chernobyl Patients from Belarus, Russia and Ukraine. Leukemia Research 2004 Dec, 28(12):1273-1280. Corrected Proof, Available online 1 July 2004,
57. Oh H, Loberiza Jr FR, Zhang MJ, Ringden O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey J, Kolb HJ, Litzow MR, McCarthy PL, Neudorf SM, Serna DS, Socie G, Tiberghien P, Barrett AJ.  Comparison of graft-vs-host-disease and survival after HLA-identical sibling bone marrow transplantation in different ethnic populations.  Blood Feb 15;105(4):1408-16, 2005. Epub 2004 Oct 14.
58. Mahoney MC, Moysich KM, McCarthy PL, McDonald RC, Stepanenko VF, Day RW, Michalek AM. The Chernobyl childhood leukemia study: background & lessons learned. Environmental Health: A Global Access Science Source 2004, 3:12 (8Nov2004)
59. Hahn T, Alam AR, Lawrence D Ford LA, Baer MR, Bambach B, Bernstein ZP, Czuczman MS, Silva J, Slack JL, Wetzler M, Becker J, McCarthy Jr PL. Thrombotic Microangiopathy After Allogeneic Blood and Marrow Transplantation is Associated with Dose Intensive Myeloablative Conditioning Regimens, Unrelated Donor and Methylprednisolone T Cell-Depletion, Transplantation. Nov 27;78(10):1515-22, 2004.
60. Hahn T, Benekli B, Wong C, Moysich KB, Hyland A, Michalek AM, Alam A, Baer MR, Bambach B, Czuczman MS, Wetzler M, Becker JL, McCarthy Jr PL. A Prognostic Model for Prolonged Event-Free Survival After Autologous or Allogeneic Blood or Marrow Transplantation for Relapsed and Refractory Hodgkin’s Disease. Bone Marrow Transplant;35(6):557-66., 2005 [Epub ahead of print], 2005.
61. Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy PL, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.   J Clin Oncol.;23(4):694-704, 2005.
62. Scarpace SL, Hahn T, Roy H, Brown K, Paplham P, Chanan-Khan A, van Besien K, McCarthy PL. Arterial Thrombosis In Four Patients Treated With Thalidomide. Leukemia & Lymphoma. 46(2):239-42. 2005
63. Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C, Wagner J, Sweetman R, McCarthy PL Chao N.  Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT).  Biology Blood Marrow Transplant.11(2):149-60, 2005
64. Shaukat A, Bakri F, Young P, Hahn T, Ball D, Baer M, Wetzler M, Slack JL, Loud P, Czuczman M, McCarthy PL, Walsh TJ, Segal BH. Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: Clinical, radiologic, and pathologic characteristics. Mycopathologia. 159(2):181-8, 2005
65. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A.  Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients.  Biol Blood Marrow Transplant. 11(5):389-98, 2005.
66. Pavletic SZ, Khouri IF, Haagenson M, King RJ, Bierman PJ, Bishop MR, Carston M, Giralt S, Molina A, Copelan EA, Ringden O, Roy V, Ballen K, Adkins DR, McCarthy P, Weisdorf D, Montserrat E, Anasetti C.  Unrelated Donor Marrow Transplantation for B-Cell Chronic Lymphocytic Leukemia After Using Myeloablative Conditioning: Results From the Center for International Blood and Marrow Transplant Research. J Clin Oncol. 23:5788-5794, 2005.
67. Iyer, RV, Hahn T, Roy, HN, Battiwalla M, Cooper M, Anderson B, Paplham P, Brown K, Bambach, B, Segal SH, McCarthy Jr PL. Long-Term Use of Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant. 11(8): 587-592, August 2005.
68. Davis S, Day RW, Kopecky KJ, Mahoney MC, McCarthy PL, Michalek AM, Moysich KB, Onstad LE, Stepanenko VF, Voilleque PG, Chegerova T, Falkner K, Kulikov S, Maslova E, Ostapenko V, Rivkind N, Shevchuk V, Tsyb AF. Childhood leukaemia in Belarus, Russia, and Ukraine following the Chernobyl power station accident: results from an international collaborative population-based case-control study. Int J Epidemiol. 2005 Nov 3; [Epub ahead of print]
69. Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld J, Weisdorf D, McCarthy Jr PL. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. Biol Blood Marrow Transplant.11:823-861, 2005
70. Battiwalla M, Hahn T, Radovic M, Roy H, Wahab A, Duman E, Bajwa R, Padmanabhan S, Becker J, Barrett AJ, McCarthy Jr PL.  Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplants but does not impact chronic GVHD incidence. Blood. 2005 Nov 10; [Epub ahead of print]
71. Khoury HJ, Loberiza FR, Ringden O, Barrett AJ, Bolwell BJ, Cahn JY, Champlin RE, Gale RP, Hale GA, Urbano-Ispizua A, Martino R, McCarthy PL, Tiberghien P, Verdonck LF, Horowitz MM.  Impact of posttransplant G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood. 107:1712-1716,2006.
72. Ramanarayanan J, Dunford LM, Baer MR, Sait SN, Lawrence W, McCarthy PL. Chronic myeloid leukemia after treatment of lymphoid malignancies: Response to imatinib mesylate and favorable outcomes in three patients. Leuk Res. 30, 701-705, 2006.
73. Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld J, Weisdorf D, McCarthy Jr PL. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Adults: An Evidence-based Review. Biol Blood Marrow Transplant. 12: 1-30, 2006.
74. Bullock JM, Smith PF, Booker BM, Loughner J, Capozzi D, McCarthy Jr PL, Shaw LM. Development of a Pharmacokinetic and Bayesian Optimal Sampling Model for Individualization of Oral Busulfan in Hematopoietic Stem Cell Transplantation.  Ther Drug Monit. 2006 Feb;28(1):62-66.
75. Tallman MS, Perez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, Garcia JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant. 12:204-16, 2006
76. Elefante A , Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T., Padmanabhan S, Battiwalla M, McCarthy PL. Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels. Bone Marrow Transplant. 37(8):781-4, 2006. Mar 6; [Epub ahead of print].
77. Marks DI, Forman SJ, Blume KG, Perez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, Trigg ME, Zhang MJ, Horowitz MM. A Comparison of Cyclophosphamide and Total Body Irradiation with Etoposide and Total Body Irradiation as Conditioning Regimens for Patients Undergoing Sibling Allografting for Acute Lymphoblastic Leukemia in First or Second Complete Remission. Biol Blood Marrow Transplant 12: 438-453, 2006
78. Rini BI, Halabi S, Barrier R, Margolin KA, Avigan D, Logan T, Stadler WM, McCarthy PL, Linker CA, Small EJ.  Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: A CALGB Intergroup Phase II Study for the Cancer and Leukemia Group B, Eastern Cooperative Oncology Group, and Southwestern Oncology Group.  Biol Blood Marrow Transplant 12:778-785 2006.
79. Benekli M, Hahn T, Williams BT, Cooper M, Roy HN, Wallace P, Stewart C, Bambach B,  McCarthy Jr  PL.  Muromonab-CD3 (Orthoclone OKT3s), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation. Bone Marrow Transplant. 38:365-370, 2006. 2006 Jul; [Epub ahead of print]
80. Anagnostopoulos A, Hari PN, Perez WS, Ballen K, Bashey A, Bredeson CN, Freytes CO, Gale RP, Gertz MA, Gibson J, Goldschmidt H, Lazarus HM, McCarthy Jr  PL, Reece DE, Vesole DH, Giralt SA.  Autologous or Allogeneic Stem Cell Transplantation in Patients with Waldenstrom’s Macroglobulinemia.  Biol Blood Marrow Transplant 12:845-854 2006.
81. Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO 3rd, Wilmot F, McCarthy Jr PL, Hahn T. The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: an Evidence-Based Review. Biol Blood Marrow Transplant 13:1-25, 2007.
82. Battiwalla M, Paplham P, Almyroudis NG, McCarthy A, Abdelhalim A, Elefante A, Smith P, Becker J. McCarthy PL, Segal BH.  Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation.  Transplant Infectious Disease 9:28-3, 2007.
83. Koutros S, Holford TR, Hahn T, Lantos PM, McCarthy PL, Risch HA, Swede H.  Excess diagnosis of non-Hodgkin’s lymphoma during spring in the USA.  Leukemia & Lymphoma, 48(2): 357-366, 2007.
84. Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL, Sobocinski KA, Horowitz MM on behalf of the Chronic Leukemia Working Committee of the Center for International Blood and Marrow Transplantation Research. Impact of Imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. Brit J Haematol, Jun;137(5):461-7, 2007
85. Padmanabhan S, Battiwalla M, Hahn T, Ball D, Paplham P, Brown K, Segal BH, McCarthy P Jr, Almyroudis NG. Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature. Transpl Infect Dis. 9: 148-152, 2007.
86. Gupta S, Almyroudis NG, Battiwalla M, Bambach BJ, McCarthy PL, Proefrock AD, Ball D, Paplham P, Varma A, Kwon-Chung J, Segal BH. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis.9: 156-60, 2007.
87. Battiwalla M, Wu Y, Bajwa RP, Radovic M, Almyroudis NG, Segal BH, Wallace PK, Nakamura R, Padmanabhan S, Hahn T, McCarthy PL. Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis. Biol Blood Marrow Transplant. 7:765-70, 2007.
88. Reddy NM, Sullivan MA, Hahn TE, Battiwalla M, SL, McCarthy PL. Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2007 Aug 27; [Epub ahead of print].

89. Yao S, McCarthy PL, Dunford LM, Roy DM, Brown K, Paplham P, Syta M, Lamonica D, Smiley S, Battiwalla M, Padmanabhan S, Hahn T. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy. Bone Marrow Transplant 2007 Nov 12; [Epub ahead of print]

90. Benekli M. Smiley SL, Younis T, Czuczman MS, Hernandez-Ilizaliturri F, Bambach B, Battiwalla M, Padmanabhan S, McCarthy, PL Jr., Hahn, T.  Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin’s lymphoma. Bone Marrow Transplant.  2007 Dec 10; [Epub ahead of print].  

91. Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn JY, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller CB, Sierra J, Milone G, Keating A, Loberiza FR Jr, Giralt S, Horowitz MM, Weisdorf DJ.  Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research.  Bone Marrow Transplant. 2007 Dec 17; [Epub ahead of print].

Chapters & Reviews

1. McCarthy Jr PL, Remold-O'Donnell E, Remold HG.  Purification and Some Properties of Guinea Pig Migration Inhibitory Factor.  In: Deweck AL, Kristensen F, Landry G, eds.  Biochemical characterization of lymphokines.  New York:  Academic Press, pp 23-29, 1980.

2. McCarthy Jr PL, Rosenthal DS.  Acute Leukemia in Adults.  In: Rakel RE, ed. Conn's Current Therapy.  Philadelphia:  W. B. Saunders, pp 354-357, 1989.

3. McCarthy Jr PL, Remold HG.  Production and Assay of Macrophage Migration Inhibitory Factor and Leukocyte Migration Inhibitory Factor.  In: Clinical Indications for Migration Inhibition Assays - Procedures - Materials.  Manual of Clinical Laboratory Immunology, 4th Ed.  American Society for Microbiology, 1992.

4. Newman G, Gan H, McCarthy PL, Remold HG.  Increased Production of TNF Alpha and IL-6 by Human Macrophages Inoculated with Mycobacterium avium Correlates with Prolonged Survival of the Cells.  In: eds. Sonnefeld G, Czamiecki G, Nacy C, Byrne G, Degre M.  Cytokines and Resistance to Nonviral Pathogenic Infections.  Augusta:  Biomedical Press, pp 23-30, 1992. 

5. McCarthy Jr PL.  Down-Regulation of Cytokine Action.  In: Brenner M ed.  Bailliere's Clinical Haematology:  Cytokines and growth factors.  7:153-177, 1994.

6. Kroll MH, McCarthy Jr PL.  Hemorrhagic and Thrombotic Complications of Bone Marrow Transplantation.  Focus on Hemostasis, Update on thrombosis and hemostasis.  3. No. 2, pp 1039-1050, 1994.

7. McCarthy Jr PL, Williams LA. Bone Marrow Transplantation Unit. In: Burt RK, Deeg J, Santos GW eds. On Call in Bone Marrow Transplantation.  Austin TX, RG Landes, pp 8-13, 1996.

8. Williams LA, McCarthy Jr PL. Patient and Donor Evaluation. In: Burt RK, Deeg J, Santos GW eds. On Call in Bone Marrow Transplantation.  Austin TX, RG Landes, pp 14-22, 1996.

9. Kroll MH, McCarthy Jr PL.  Hemostatic Complications of Bone Marrow Transplantation.  In:  Loscalzo J, Schafer AI eds.  Thrombosis and Hemorrhage.  Boston:  Blackwell Scientific Publications, 2nd edition, pp 1077-1090, 1998.  

10. McCarthy Jr PL. Clinician Perspective on Indwelling Central Venous Access Devices. Seminars in Interventional Radiology 15:249-252, 1998.

11. McCarthy Jr PL, Polycythemia Vera.  In: Rakel RE, ed. Conn's Current Therapy.  Philadelphia: W.B. Saunders, pp 440-442, 1999.

12. McCarthy Jr PL, Hurd DD, Rowlings PA, Murphy SC, Antman KS, Armitage JO, Cirenza E, Crump M, Doroshower J, Freytes CO, Gale RP, Kalman LA, Lazarus HM, Vaughn WP, Weinberger BB, Wienmann MC, Horowitz MM. Autotransplantation for Men with Breast Cancer  In: Karel A. Dicke & Armand Keating, ed.  Autologous Blood and Marrow Transplantation    Virginia: Carden Jennings, pp 275-278, 1999.

13. McCarthy Jr PL, Williams LA, Holmes M.  Stem Cell Transplantation: Past, Present and Future.  In: Buchsel PC, Kapustay PM eds. Stem Cell Transplantation: A Clinical Textbook  Pittsburgh: Oncology Nursing Press, Inc. pp 3.1-3.24, 2000

14. Williams LA, McCarthy Jr PL.  Diseases Treated with Peripheral Stem Cell Transplantation In: Buchsel PC, Kapustay PM eds. Stem Cell Transplantation: A Clinical Textbook  Pittsburgh: Oncology Nursing Press, Inc. pp 1.1-1.20, 2000

15. Czuczman MS, Fallon A, Mohr A, Stewart C, Bernstein ZP, McCarthy P, Skipper M, Brown K, Miller K, Wentling D, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez AJ, Bernstein SH.  Rituximab in combination with CHOP or Fludarabine in low-grade lymphoma.  Seminars in Oncology 29: (1) (suppl 2):  36-40, 2002

16. Leising L, McKernon M, Dunford L, Hahn T, McCarthy Jr PL.  Safety of Water Consumption Among Hematopoietic Stem Cell Transplant Recipients:  Support Line 28: (4) 13-17 2006.

Editorials/Commentary/Letters

1. McCarthy Jr P.  Treatment of Metastatic Breast Cancer with Intensive Chemotherapy.  Neoplasia, Vol. 10, No. 6, November-December 1993.

2. Williams L, McCarthy PL.  When is Dose Intensity Important in the Treatment of Malignant Disease?  ONS Bone Marrow Transplant SIG Newsletter 5, No. 2, 1994.

3. McCarthy PL, Williams L.  Bone Marrow Transplantation for Sickle Cell Anemia.  Sickle-Scope (Newsletter of the Sickle Cell Association of the Texas Gulf Coast) 3, No. 4, 1994.

4. McCarthy Jr PL, A Perspective on Clinical Disorders of Radiation Accident Victims. Radiation Injury and the Chernobyl Catastrophe. Stem Cells 15: (suppl 2) 121-124, 1997.

5. McCarthy Jr PL, BMT and Breast Cancer.  Cancer Report, Roswell Park Cancer Institute, pp 3, July 1999

6. Van Besien K, Champlin R, Khouri I, McCarthy P.  Allogeneic transplantation for low-grade lymphoma:  long-term follow-up.  J Clin Oncol 18(3):702-3, February 2000

7. Jones R, Horowitz, M, Wall D, Wingard J, Wolff S, McCarthy P, Hahn T.  ASBMT policy statement regarding the methodology of evidence-based reviews in evaluating the role of blood and marrow transplantation in the treatment of selected diseases.  Biology of Blood and Marrow Transplantation: 6:524-525, 2000

8. Younis TH, Alam A, Paplham P, Spangenthal E, McCarthy P.  Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma.  Br J Haematol 123:563, 2003.

9. McCarthy PL.  Book Review:  Allogeneic stem cell transplantation.  Oncology 66:77-78, 2004

10. Younis T, McCarthy P. Reply to Hattori et al: Thalidomide and pulmonary hypertension. A causal or casual relationship? Br J Haematol. 2005 Mar;128 (6):887-8. 

11. Hahn T, McCarthy PL. Response to Tey et al. Bone Marrow Transplant. 2005 Jul 25; [Epub ahead of print]

12. Jones R, Nieto Y, Rizzo JD, Wall D, Wingard JR, McCarthy Jr, P, Hahn T. The Evolution of the Evidence-Based Review: Evaluating the Science Enhances the Art of Medicine-Statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2005 Nov;11(11):819-22

13. Dunford LM, Roy DM, Hahn TE, Padmanabhan S, Segal BH, Almyroudis N, McCarthy Jr, PL, Battiwalla M. Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 Feb;12(2):241-2.

14. Battiwalla M, Hahn T, McCarthy PL Jr. HLA-DR15 and Immunobiologic Outcomes. Biol Blood Marrow Transplant. 13: 371, 2007.

15. McCarthy PL. “Stimulate the Phagocytes!” Fascin-ating! Are DCs actin’up? Comment on Geyeregger et al.. Blood 109: 4112-4113, 2007.